Draft genome and description of Merdibacter massiliensis gen.nov., sp. nov., a new bacterium genus isolated from the human ileum.


Journal

Scientific reports
ISSN: 2045-2322
Titre abrégé: Sci Rep
Pays: England
ID NLM: 101563288

Informations de publication

Date de publication:
28 05 2019
Historique:
received: 21 11 2018
accepted: 09 05 2019
entrez: 30 5 2019
pubmed: 30 5 2019
medline: 21 10 2020
Statut: epublish

Résumé

We used phenotypic, genomic and phylogenetic information following the taxono-genomics approach to demonstrate that strain Marseille-P3254, isolated from an ileal sample of a 76-year old woman who underwent upper and lower digestive tract endoscopy for esophagitis and colonic polyp, is representative of a novel bacterial genus within the family Erysipelotrichaceae in the phylum Firmicutes. It is an anaerobic Gram-negative bacterium without catalase and oxidase activities. The genome of strain Marseille-P3254 is 2,468,496-bp long with a 40.1% G + C content. This new bacterium is most closely related to Eubacterium dolichum, with which it shares 90.7% 16S rRNA sequence similarity. In addition, genomic comparison using the digital DNA-DNA hybridization and OrthoANI analyses between the novel organism and the E. dolichum type strain revealed identities of 25.2 and 68.91%, respectively. The major fatty acids were C

Identifiants

pubmed: 31138831
doi: 10.1038/s41598-019-44343-8
pii: 10.1038/s41598-019-44343-8
pmc: PMC6538751
doi:

Substances chimiques

DNA, Bacterial 0

Types de publication

Journal Article Research Support, Non-U.S. Gov't

Langues

eng

Sous-ensembles de citation

IM

Pagination

7931

Références

Stand Genomic Sci. 2013 Jun 13;8(2):336-51
pubmed: 23991263
Clin Microbiol Infect. 2012 Dec;18(12):1185-93
pubmed: 23033984
Int J Syst Evol Microbiol. 2014 Feb;64(Pt 2):384-391
pubmed: 24505076
Bioinformatics. 2011 Oct 1;27(19):2756-7
pubmed: 21810901
Int J Syst Evol Microbiol. 2015 Mar;65(Pt 3):805-810
pubmed: 25481294
Genome Biol. 2012 Jun 25;13(6):R56
pubmed: 22731987
Stand Genomic Sci. 2015 Nov 14;10:103
pubmed: 26568786
J Clin Microbiol. 2000 Oct;38(10):3623-30
pubmed: 11015374
Clin Infect Dis. 2009 Aug 15;49(4):543-51
pubmed: 19583519
Antonie Van Leeuwenhoek. 2017 Oct;110(10):1327-1337
pubmed: 28389704
Nat Microbiol. 2016 Nov 07;1:16203
pubmed: 27819657
Bioinformatics. 2011 Feb 1;27(3):431-2
pubmed: 21149340
Int J Syst Evol Microbiol. 2016 Feb;66(2):1100-1103
pubmed: 26585518
Antimicrob Agents Chemother. 2014;58(1):212-20
pubmed: 24145532
J Clin Microbiol. 2013 Jul;51(7):2182-94
pubmed: 23637301
Bioinformatics. 2011 Feb 15;27(4):578-9
pubmed: 21149342
Gut Microbes. 2016;7(2):154-62
pubmed: 26900998
Annu Rev Food Sci Technol. 2015;6:137-56
pubmed: 25532597
Nucleic Acids Res. 2014 Jan;42(Database issue):D581-91
pubmed: 24225323
Anaerobe. 2017 Dec;48:70-75
pubmed: 28754474
New Microbes New Infect. 2016 Nov 24;15:89-91
pubmed: 28050253
ISME J. 2012 Jul;6(7):1415-26
pubmed: 22258098
BMC Bioinformatics. 2013 Feb 21;14:60
pubmed: 23432962
Nucleic Acids Res. 2017 Jan 4;45(D1):D353-D361
pubmed: 27899662
Stand Genomic Sci. 2016 Apr 14;11:32
pubmed: 27087892
Int J Syst Evol Microbiol. 2014 Nov;64(Pt 11):3877-3884
pubmed: 25180093
Stand Genomic Sci. 2013 Dec 15;9(2):395-409
pubmed: 24976895
Clin Microbiol Rev. 2015 Jan;28(1):237-64
pubmed: 25567229
Stand Genomic Sci. 2010 Jan 28;2(1):117-34
pubmed: 21304684
J Comput Biol. 2012 May;19(5):455-77
pubmed: 22506599
Wiley Interdiscip Rev Syst Biol Med. 2015 Jul-Aug;7(4):195-219
pubmed: 25929487
PLoS One. 2013 Oct 28;8(10):e77302
pubmed: 24204795
Nat Rev Gastroenterol Hepatol. 2012 Sep 04;9(10):577-89
pubmed: 22945443
Nucleic Acids Res. 2015 Jul 1;43(W1):W237-43
pubmed: 25948579
New Microbes New Infect. 2016 Jan 11;10:66-76
pubmed: 26937282
Mol Biol Evol. 2016 Jul;33(7):1870-4
pubmed: 27004904

Auteurs

Hussein Anani (H)

Aix Marseille Univ, Institut de Recherche pour le Développement (IRD), Service de Santé des Armées, AP-HM, UMR Vecteurs Infections Tropicales et Méditerranéennes (VITROME), Institut Hospitalo-Universitaire Méditerranée Infection, Marseille, France.

Rita Abou Abdallah (R)

Aix Marseille Univ, Institut de Recherche pour le Développement (IRD), Service de Santé des Armées, AP-HM, UMR Vecteurs Infections Tropicales et Méditerranéennes (VITROME), Institut Hospitalo-Universitaire Méditerranée Infection, Marseille, France.

Nisrine Chelkha (N)

Aix-Marseille Université, Institut de Recherche pour le Développement (IRD), UMR Microbes Evolution Phylogeny and Infections (MEPHI), Institut Hospitalo-Universitaire Méditerranée-Infection, Marseille, France.

Anthony Fontanini (A)

Aix-Marseille Université, Institut de Recherche pour le Développement (IRD), UMR Microbes Evolution Phylogeny and Infections (MEPHI), Institut Hospitalo-Universitaire Méditerranée-Infection, Marseille, France.

Davide Ricaboni (D)

Aix-Marseille Université, Institut de Recherche pour le Développement (IRD), UMR Microbes Evolution Phylogeny and Infections (MEPHI), Institut Hospitalo-Universitaire Méditerranée-Infection, Marseille, France.

Morgane Mailhe (M)

Aix-Marseille Université, Institut de Recherche pour le Développement (IRD), UMR Microbes Evolution Phylogeny and Infections (MEPHI), Institut Hospitalo-Universitaire Méditerranée-Infection, Marseille, France.

Didier Raoult (D)

Aix-Marseille Université, Institut de Recherche pour le Développement (IRD), UMR Microbes Evolution Phylogeny and Infections (MEPHI), Institut Hospitalo-Universitaire Méditerranée-Infection, Marseille, France.
Special Infectious Agents Unit, King Fahd Medical Research Center, King Abdulaziz University, Jeddah, Saudi Arabia.

Pierre-Edouard Fournier (PE)

Aix Marseille Univ, Institut de Recherche pour le Développement (IRD), Service de Santé des Armées, AP-HM, UMR Vecteurs Infections Tropicales et Méditerranéennes (VITROME), Institut Hospitalo-Universitaire Méditerranée Infection, Marseille, France. pierre-edouard.fournier@univ-amu.fr.

Articles similaires

Genome, Chloroplast Phylogeny Genetic Markers Base Composition High-Throughput Nucleotide Sequencing

[Redispensing of expensive oral anticancer medicines: a practical application].

Lisanne N van Merendonk, Kübra Akgöl, Bastiaan Nuijen
1.00
Humans Antineoplastic Agents Administration, Oral Drug Costs Counterfeit Drugs

Smoking Cessation and Incident Cardiovascular Disease.

Jun Hwan Cho, Seung Yong Shin, Hoseob Kim et al.
1.00
Humans Male Smoking Cessation Cardiovascular Diseases Female
Humans United States Aged Cross-Sectional Studies Medicare Part C

Classifications MeSH